Advertisement

Topics

Seqirus Company Profile

22:25 EST 15th December 2018 | BioPortfolio

In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.1,2 CVVs are prepared by the World Health Organization (WHO) Global Influenza Surveillance and Response System (GISRS) and associated laboratories, and are used by manufacturers to develop and produce influenza vaccines.


News Articles [16 Associated News Articles listed on BioPortfolio]

Seqirus Receives FDA Approval for New Mfg. Process

Will enable Seqirus to double current production levels of FLUCELVAX® QUADRIVALENT for supply in the 2019/20 flu season

CSL's Seqirus expects to double flu vaccine production at NC plant

Coming off one of the worst U.S. flu seasons in the last decade, the FDA has approved a new process that Seqirus believes will improve the way cells are grown at its Holly Springs site.

Human Vaccines Project and Seqirus collaborate to accelerate universal flu vaccine research

The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, and Seqirus, a global leader in the prevention of influenza, announced...

US FDA approves Seqirus' next generation cell─based influenza vaccine manufacturing process

Seqirus, a global leader in influenza vaccine innovation, has announced FDA approval of its next generation cell─based manufacturing process at Holly Springs, North Carolina. The approval will enabl...

Adding 120 N.C. Jobs, Seqirus to Spend $140 Million to Expand Flu Vaccine Plant

Seqirus, a wholly owned subsidiary of CSL, is expanding its manufacturing plant in North Carolina. It expects to invest $140 million in the expansion.

Adding 120 N.C. Jobs, Seqirus to Spend $140 Million to Expands its Flu Vaccine Manufacturing Plant

Seqirus, a wholly owned subsidiary of CSL, is expanding its manufacturing plant in North Carolina. It expects to invest $140 million in the expansion.

Human Vaccines Project and Seqirus partner to advance universal flu vaccine research

(Human Vaccines Project) The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, announced today that Seqirus, a global leader...

FDA expands use of Seqirus' influenza vaccines

Seqirus' influenza vaccines Afluria and Afluria Quadrivalent were approved by the FDA for use in patients at least 6 months o -More- 

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

This is a study to assess the immune (antibody) response and safety of a Seqirus split virion, inactivated Quadrivalent Influenza Vaccine (Seqirus QIV), in comparison with a US licensed 20...

Seqirus 2017 H7N9 With/Without MF59 (R) in Healthy Males and Non-pregnant Females, 18-64 Years of Age.

This is a randomized, double-blinded, Phase II study in healthy males and non-pregnant females, 18-64 years of age. This clinical trial is designed to assess the safety, reactogenicity, an...

Companies [1 Associated Companies listed on BioPortfolio]

Seqirus

In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in ...

More Information about "Seqirus" on BioPortfolio

We have published hundreds of Seqirus news stories on BioPortfolio along with dozens of Seqirus Clinical Trials and PubMed Articles about Seqirus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Seqirus Companies in our database. You can also find out about relevant Seqirus Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Influenza
Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...


Corporate Database Quicklinks



Searches Linking to this Company Record